Opdivo®+Yervoy®
Opdivo® (nivolumab) is a prescription medicine used in combination with Yervoy® (ipilimumab) and 2 cycles of chemotherapy that contains platinum and another chemotherapy medicine, as a first treatment for adults with a type of advanced stage lung cancer (called non-small cell lung cancer) when your lung cancer has spread or grown, or comes back, and your tumor does not have an abnormal EGFR or ALK gene.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Bristol Myers Squibb |
CLASS: immunotherapies |
PRESCRIBED BY: Pulmonologist
|
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Every three weeks
|
Length of infusion: 60 - 90 mins |